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Abstract
Background: Traffic emissions including diesel engine exhaust are associated with increased respiratory and
cardiovascular morbidity and mortality. Controlled human exposure studies have demonstrated impaired vascular
function after inhalation of exhaust generated by a diesel engine under idling conditions.
Objectives: To assess the vascular and fibrinolytic effects of exposure to diesel exhaust generated during urban-
cycle running conditions that mimic ambient ‘real-world’ exposures.
Methods: In a randomised double-blind crossover study, eighteen healthy male volunteers were exposed to diesel
exhaust (approximately 250 μg/m
3) or filtered air for one hour during intermittent exercise. Diesel exhaust was
generated during the urban part of the standardized European Transient Cycle. Six hours post-exposure, vascular
vasomotor and fibrinolytic function was assessed during venous occlusion plethysmography with intra-arterial
agonist infusions.
Measurements and Main Results: Forearm blood flow increased in a dose-dependent manner with both
endothelial-dependent (acetylcholine and bradykinin) and endothelial-independent (sodium nitroprusside and
verapamil) vasodilators. Diesel exhaust exposure attenuated the vasodilatation to acetylcholine (P < 0.001),
bradykinin (P < 0.05), sodium nitroprusside (P < 0.05) and verapamil (P < 0.001). In addition, the net release of
tissue plasminogen activator during bradykinin infusion was impaired following diesel exhaust exposure
(P < 0.05).
Conclusion: Exposure to diesel exhaust generated under transient running conditions, as a relevant model of
urban air pollution, impairs vasomotor function and endogenous fibrinolysis in a similar way as exposure to diesel
exhaust generated at idling. This indicates that adverse vascular effects of diesel exhaust inhalation occur over
different running conditions with varying exhaust composition and concentrations as well as physicochemical
particle properties. Importantly, exposure to diesel exhaust under ETC conditions was also associated with a novel
finding of impaired of calcium channel-dependent vasomotor function. This implies that certain cardiovascular
endpoints seem to be related to general diesel exhaust properties, whereas the novel calcium flux-related effect
may be associated with exhaust properties more specific for the ETC condition, for example a higher content of
diesel soot particles along with their adsorbed organic compounds.
* Correspondence: anders.blomberg@lung.umu.se
1Department of Public Health and Clinical Medicine, Respiratory Medicine,
Umeå University, Umeå, Sweden
Barath et al. Particle and Fibre Toxicology 2010, 7:19
http://www.particleandfibretoxicology.com/content/7/1/19
© 2010 Barath et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Background
Increasing attention has been directed towards the
adverse health effects associated with particulate matter
(PM) air pollution in terms of both respiratory and car-
diovascular morbidity and mortality [1-3]. Changes in
air pollution levels over previous decades account for as
much as 17% of the change in life expectancy over this
period [4]. Several studies have pointed towards traffic-
related air pollution as being of particular concern.
Living or going to school in proximity to major thor-
oughfares is associated with reduced lung growth in
children and increased risk of asthma, as well as cardio-
vascular events including increased atherosclerosis and
left ventricular hypertrophy in adult populations [5-10].
In a pivotal study, Peters and co-workers demon-
strated that patients admitted with myocardial infarction
were three times more likely to have been in traffic in
the hours prior to the onset of symptoms, suggesting a
causal link to the triggering of acute coronary events.
The authors identified an association between traffic
exposure and the onset of chest pain immediately and
six hours prior to the event, indicating that more than
one mechanism is likely to be involved [11].
Emissions from motor vehicles, in particular combus-
tion-derived particles from diesel engines, contribute to up
to 40% of urban PM and are thought to play a major role
in the adverse effects of PM. Experimental exposure stu-
dies in healthy and asthmatic individuals have demon-
strated oxidative stress, airway inflammation and
worsening of asthma, as well as acute cardiovascular events
[12-17]. Recent studies have confirmed that diesel exhaust
(DE), generated during idling engine conditions, causes
endothelial dysfunction, arterial stiffness, decreased fibri-
nolytic capacity, increased platelet activation and increased
ex-vivo thrombus formation in the first 24 hours following
exposure [12-14,18]. Furthermore, patients with stable cor-
onary heart disease experienced more ST-segment depres-
sion with exercise during exposure to diesel exhaust as
compared to filtered air [19]. Additionally, diesel exhaust
inhalation impaired endogenous fibrinolytic capacity in
these patients with reduced endothelial release of tissue
plasminogen activator (t-PA) six hours following exposure.
The time course of these adverse vascular and prothrom-
botic effects is consistent with the observation of an
immediate and delayed association between traffic expo-
sure and the onset of acute myocardial infarction [20].
Diesel exhaust particles (DEP) generated under differ-
ent engine running conditions vary in size and chemical
composition. It is therefore of interest to elucidate the
associations between physicochemical properties of the
DEP and health effects caused by exposure to DE gener-
ated under various engine running conditions. In general,
the mass of emitted DEP is often dominated by
carbonaceous agglomerated soot particles, typically 50-
300 nm, while the number concentration is dominated
by smaller particles, below 50 nm, mainly composed of
volatile organic material and sulphur compounds.
Adsorbed organic compounds, as well as small amounts
of sulphate, nitrate, metals and other trace elements are
generally also associated with the diesel exhaust. Further,
a fraction of fuel and lube oil generally escape oxidation
in the engine and are emitted as exhaust PM, consisting
of different organic compounds including polycyclic aro-
matic hydrocarbon (PAH) compounds [21,22].
People living in urban areas are mainly exposed to
particulate emissions generated during acceleration and
deceleration conditions rather than from idling engines.
We have therefore designed a human exposure system
using the standardized European Transient Cycle (ETC)
urban sequence that better reflects the exposures gener-
ated in ambient urban settings. The aim of the present
study was to determine whether inhalation of dilute die-
sel exhaust generated during the ETC urban sequence
would affect vasomotor function and fibrinolytic capa-
city in healthy human subjects, in a similar or different
way as following exposure to diesel exhaust generated
under idling conditions.
Methods
Subjects
Eighteen healthy non-smoking males mean age 27 years
(range 21-30 years) with normal lung function were
included in the study, following a standardized clinical
examination. All were free from symptoms of respira-
tory tract infections for at least 6 weeks prior to and
during the study. Female subjects were not included due
to the potential for cyclical hormones to affect vascular
responses. The study was approved by the local ethics
committee. All volunteers gave their written informed
consent and the study was performed in accordance to
the Declaration of Helsinki.
Study design
The subjects were exposed to filtered air and diesel
exhaust for one hour according to a randomized, dou-
ble-blind, cross-over design with an interval of 42 (22-
62) days between visits [15,23]. During each exposure,
the subjects performed moderate exercise (average min-
ute ventilation, 20 L/min/m
2 body surface) on a bicycle
ergometer alternating with rest at 15-minute intervals.
Based on previous exposure studies exploring respira-
tory and cardiovascular effects of diesel exhaust
[12,13,15,17], vascular assessments using venous forearm
plethysmography were performed 6-hours after diesel and
filtered air exposure. All subjects refrained from alcohol
for 24-hours and from food and caffeine-containing
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They were not allowed to carry out strenuous exercise
during the day of exposure. The studies were carried out
in a quiet, temperature-controlled room maintained at
22°C to 24°C, with subjects in the supine position.
Diesel exhaust exposure
The exposures were performed in a specially built and
validated human exposure chamber that has been
described in detail elsewhere [23]. Diesel exhaust (DE)
was generated by a diesel engine from 1991 (Volvo
TD40 GJE, 4.0 L, four cylinders) connected to an engine
dynamometer and running under control of a computer
program according to the European Transient Cycle
(ETC). The ETC is a well-established running condition
for standardized tests of engines and vehicles and is
designed to mimic real life running conditions for vehi-
cles in an urban environment. As such, it is based on
authentic recordings of accelerations and retardations,
with variations in engine load as well as periods with
constant speed. The running of the engine was con-
trolled adjusting the actions of the injection system and
an engine dynamometer that varied the load of the
engine. The ETC test cycle has been introduced
together with the European Stationary Cycle (ESC), for
emission certification of heavy-duty diesel engines in
Europe (Directive 1999/96/EC). The ETC comprises
three different driving conditions, including urban, rural
and motorway. In this study we used only the urban
driving part, representing city driving with a maximum
speed of 50 km/h, frequent starts, stops, and idling, i.e.
transient engine running conditions (Figure 1).
The diesel fuel used was Statoil class 1; cetane number
54; aromatics, 4% volume; polycyclic aromatic hydrocar-
bons, < 0.02 vol-%; sulphur < 1ppm. The initial boiling
point was 195°C and 95% volume boiling point was
280°C. More than 90% of the exhaust was shunted away
and the remaining part was accumulated in an approxi-
mately 1 m
3 container in order to smooth the concen-
tration variation during the transient running
conditions. A partial flow of DE was continuously
drawn from the container, diluted with filtered air and
fed into the exposure chamber, giving a particle mass
concentration of approximately 250 μg/m
3 in the expo-
sure chamber.
The particle mass concentration (as PM10)o fd i e s e l
exhaust particles (DEP) in the chamber during the expo-
sures was measured gravimetrically employing standard
glass fibre filter sampling as well as monitored with a
Tapered Element Oscillating Microbalance (TEOM
1400) instrument (at 50°C). Measurements of NOx,N O
and NO2 were performed with standard instruments
using a chemiluminescence technique (ECO Physics
CLD 700 AL Med, Switzerland). Total hydrocarbon in
the exposure aerosol was measured using a flame ioniza-
tion detection method (Hydrocarbon Analyzer, Model 3-
300, JUM Engineering Co, Oakland, California, USA).
Data on exposure characteristics are given in Table 1.
Extensive physicochemical characterisation of the DEP
in the chamber was performed on a single occasion
after the campaign, but under the same conditions as
during the exposures. The aerodynamic particle mass
size distribution in the range of 0.03-10 μm was deter-
mined using a 13 stage low-pressure cascade impactor
(Dekati Ltd, Tampere, Finland). As seen in Figure 2, fine
particles (< 1 μm) totally dominated the PM mass in the
chamber and the fine mode aerodynamic mass median
diameter (MMDa) was determined to be 116 nm
(Table 1).
A scanning mobility particle sizer (SMPS) was used to
classify the particles regarding their number, size distri-
bution and concentration within 0.013 to 0.380 μm
(equivalent mobility diameter). The system consisted of
a differential mobility analyzer (DMA) (TSI model
3071A, TSI, St Paul, Minnesota, USA) and a condensa-
tion particle counter (CPC) (TSI model 3010, TSI,
St Paul, Minnesota, USA). Relatively long scan times,
i.e. 120 s up and 40 s down, were used to enable pur-
ging of the system between the scans. Aerosol flow was
set to 1 L/min and sheath air flow to 7 L/min. The aver-
age total number concentration of fine particles in the
chamber (normalized to a mass concentration of 300
μg/m
3) and average count median (equivalent mobility)
diameter (CMDm) are shown in Table 1 and Figure 3.
The DEP were characterized chemically regarding car-
bon fractionation (organic/elemental carbon), PAH and
trace elements. The fraction of organic and elemental
carbon of the PM in the chamber was determined by
thermal-optical carbon analysis (Method NIOSH 5040)
using quartz and teflon+quartz filters in parallel accord-
ing to standard procedures [24]. “Elemental carbon” is
Figure 1 The urban sequence of the European Transient Cycle
applied in the present study.
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and the result therefore implies that the mass of DEP
during the present ETC conditions was dominated by
soot particles (Table 1).
PAH were sampled by glass fiber filter sampling (dia-
meter 47 mm) for the particulate fraction followed by a
polyurethane foam (PUF) plug (diameter 75 mm ×
50 mm) for the semi-volatile fraction. Forty-nine PAH
compounds were analyzed by gas chromatography-mass
spectrometry (GC-MS) for quantification in the particu-
late and semi-volatile fractions, respectively, according
to procedures described in more detail elsewhere
[25-27]. A total PAH concentration (normalized to a
mass concentration of 300 μg/m
3)o f0 . 9 6μg/m
3 was
Table 1 Exposure characteristics of the present study during European Transient Cycle urban conditions compared to
earlier studies [12,14] during idling engine conditions.
ETC urban
present study
Idling
previous study
Exposure campaigns
Diesel engine Volvo TD40, 4.0 L, four cylinders Volvo TD45, 4.5 L four cylinders
Diesel fuel Diesel class I Diesel class III
PM10 mass concentration (filter), μg/m
3 254 ± 36 330 ± 12
(3)
PM10 mass concentration (TEOM), μg/m
3 228 ± 19 -
NOx, ppm 7.5 ± 0.3 2.8 ± <0.1
(3)
NO2, ppm 0.9 ± 0.1 0.6 ± <0.1
(3)
NO, ppm 6.6 ± 0.3 2.2 ± <0.1
(3)
Total hydrocarbons (THC), ppm 1.2 ± 0.2 1.6 ± 0.2
(3)
Complementary measurements
(1)
Particle number concentration, #/cm
3 1.2 × 10
5 9.5 × 10
5( 4 )
Particle count median size (CMDmobility), nm 129 55
(4)
Particle mass median size (MMDaerodynamic) nm 116 199
(4)
Organic carbon fraction (OC/TC
(2)), % 12 94.5
(4)
Elemental carbon fraction (EC/TC
(2)), % 88 5.5
(4)
Total PAH concentration, μg/m
3 0.96 3.5
(4)
Semi-volatile PAH concentration, μg/m
3 0.69 3.4
(4)
PM-associated PAH concentration, μg/m
3 0.27 0.16
(4)
(1) Particle number and PAH concentrations normalized to a PM mass concentration of 300 μg/m
3 to enable a comparison between ETC and idling conditions.
(2) TC = Total carbon content in PM mass
(3) Exposure protocol data from a previously reported study [14]
(4) Un-published DEP characteristics data associated with the exposure conditions during the previously reported studies [12,14]
For the exposure campaign data, mean values are given mean ± std.dev.
Figure 2 Mass size distribution of diluted diesel exhaust
particles in the exposure chamber during the urban running
part of the European Trancient Cycle. MMDa for the fine mode
was 0.116 μm.
Figure 3 Number size distribution of diluted diesel exhaust
particles in the exposure chamber during the urban running
part of the European Transient Cycle. Standard deviations for 3
scans are shown as error bars. A log-normal fitting calculation
showed that the size distribution comprised in principal only one
single mode.
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3 in
the semi-volatile fraction and 0.27 μg/m
3 as particulate
associated (Table 1). This implies that PAH constituted
< 1% of the total DEP mass in the chamber. During the
idling engine conditions, the PAHs contributing most to
the atmosphere in the exposure chamber were phenan-
threne and methyl derivatives of phenanthrene, equiva-
lent to more than 80% of the PAHs determined. The
corresponding value for the transient engine load (urban
part of ETC) was more than 75%.
Determination of oxidative properties of particles
DEP were collected using a high volume cascade sam-
pler with a multi-stage round slit nozzle impactor,
within the exposure chamber under both idling and
transient (ETC urban part) engine conditions. Coarse
and fine diesel particles were collected onto polyur-
ethane foams by impaction [28] and extracted from the
collection substrate with methanol using extensive vor-
texing and sonication, as described previously [29]. PM
oxidative activity was assessed in a synthetic respiratory
tract lining fluid (RTLF) on an equal mass basis (50 μg/
mL). This involved establishing the capacity of fine
(PM0.1-2.5) and coarse (PM2.5-10) samples to deplete
ascorbate (AA), glutathione (GSH) and urate (UA), each
at a starting concentration of 200 μM, over a 4-h incu-
bation period (37°C). After the 4-h incubation period,
samples were either acidified with metaphosphoric acid
to a final concentration of 5% (w/v) for UA andAA mea-
surement, or diluted into 100 mM phosphate buffer for
the determination of glutathione (GSH). Methodological
details for these antioxidant determinations have been
described previously [30]. The final PM oxidative poten-
tials (OP) were expressed as the percentage loss of
either AA (OP
AA) or GSH (OP
GSH) over the 4-h incuba-
tion, relative to the particle free control, expressed per
μg of extracted PM. The OP values associated with the
coarse and fine fraction for each antioxidant were com-
bined to derive an expression for PM0.1-10.U r a t ew a s
n o tl o s tf r o mt h es y n t h e t i cR T L Fw i t ha n yo ft h eP M
samples tested.
Vascular studies
Forearm blood flow (FBF) was measured during unilat-
eral brachial artery infusion of endothelial-dependent
and -independent vasodilators using venous occlusion
plethysmography with mercury-in-silicone elastomer
strain gauges, as described previously [12]. Briefly, the
brachial artery of one arm was cannulated with 27-stan-
dard wire gauge steel needle and 17 gauge venous can-
nulae were inserted in large veins in the antecubital
fossa of both arms. Following a 30-minute baseline sal-
ine infusion, acetylcholine 5, 10, and 20 μg/min
(endothelium-dependent vasodilator which does not
release tissue plasminogen activator [t-PA]; Merck Bios-
ciences); bradykinin at 100, 300, and 1,000 pmol/min
(endothelium-dependent vasodilator which releases t-
PA; Merck Biosciences); and sodium nitroprusside
( S N P )2 ,4 ,a n d8μg/min (endothelium-independent
vasodilator which does not release t-PA; David Bull
Laboratories) were infused for 6 minutes at each dose
with FBF measured for the last 3 minutes of each infu-
sion. The infusions of the three vasodilators were given
in a random order and separated by 20-minute saline
infusions. Verapamil at 10, 30, and 100 μg/min
(endothelium-and NO-independent vasodilator which
does not release t-PA) was infused at the end of the
study protocol due to its prolonged action. Blood pres-
sure and heart rate were measured during the forearm
study using a validated semi-automated oscillometric
sphygmanometer.
Blood (10 mL) was withdrawn simultaneously from
each arm at baseline and during infusion of each dose
of bradykinin and collected into acidified buffered citrate
(Stabilyte tubes, Biopool International) for tissue plasmi-
nogen activator (t-PA) assay. The samples were kept on
ice until centrifuged at 2,000 g for 30 minutes at 4°C.
Platelet-free plasma was decanted and stored at -80°C
before assay. Plasma t-PA antigen concentrations were
determined by ELISA (TintElize t-PA, Biopool EIA).
Hematocrit was determined by capillary tube centrifuga-
tion at baseline and at the end of the study protocol.
Markers of systemic inflammation
Peripheral blood samples were taken immediately before
and 2 and 6 hours post-exposure and were analyzed for
total and differential cell counts by an autoanalyzer in
the local clinical biochemistry reference laboratory
(Umeå University Hospital, Umeå, Sweden). Serum and
plasma were prepared for measurement of interleukin-6
(IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble
P-selectin, soluble intracellular adhesion molecule-1
(ICAM-1) and CD40 ligand using commercially available
ELISAs (Quantikine, R&D Systems). Serum C-reactive
protein (CRP) was measured using an immunonephelo-
metric assay (Behring BN II nephelometer).
Data analysis and statistics
Plethysmographic data were analyzed as described pre-
viously [31]. The net release of t-PA antigen was defined
as the product of the infused forearm plasma flow
(based on the mean hematocrit and the infused FBF)
and the concentration difference between the infused
and non-infused arms as described previously [31]. Data
were analysed by 2-way ANOVA with repeated mea-
sures or 2-tailed Student’s t-tests, where appropriate,
using GraphPad Prism (GraphPad Software, Version 4
for Macintosh) and SPSS (SPSS inc. Chicago, IL, USA,
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tistical significance was taken at p < 0.05.
Results
Exposure characteristics
Compared to the idling situation, exposure data from
the ETC urban running condition revealed that the par-
ticles were larger but lower in number, despite similar
mass concentration. During ETC, the fraction of organic
carbon/elemental carbon was reduced, indicating higher
soot content, and the total PAH concentration was
reduced compared to the idling situation. Furthermore,
NOx levels were increased under ETC, although the oxi-
dative potential of the diesel particles was reduced
(Table 1).
Oxidative potential
Determination of oxidative potential (OP) of the PM
samples demonstrated that DEP generated under the
present ETC urban engine conditions were less oxidiz-
ing (PM0.1-10 OP
GSH = 0.15 ± 0.12%/μg, PM0.1-10 OP
AA
= 0.25 ± 0.13%/μg) than DEP generated under presently
studied idling engine conditions (PM0.1-10 OP
GSH =0 . 4 3
± 0.11%/μg, PM0.1-10 OP
AA = 0.43 ± 0.16%/μg, ETC ver-
sus idling engine). The oxidative properties observed
from both these experimental tail-pipe emissions were
minor compared with those observed in a previous
study of ambient PM samples collected from roadside
sites (OP
GSH = 0.60 ± 0.45 and OP
AA =1 . 2 6±
0.37) [32].
Vascular and fibrinolytic function
There were no differences in resting heart rate, blood
pressure, or baseline FBF (P > 0.05 for all) after expo-
sure to diesel exhaust or filtered air (Table 2). All infu-
sions of vasoactive drugs increased blood flow in a dose
dependent manner (P < 0.001). Diesel exhaust exposure
significantly attenuated the increase in forearm blood
flow during infusions of both endothelium-dependent
and -independent vasodilators, as compared with filtered
air exposure (P < 0.05 for bradykinin, P < 0.001 for acet-
ylcholine, P < 0.05 for sodium nitroprusside and P <
0.001 for verapamil( Figure 4).The net release of t-PA
following bradykinin infusion was reduced (P < 0.05)
after exposure to diesel exhaust compared with filtered
air (Figure 5).
Systemic inflammation
Peripheral blood leukocyte, neutrophil and platelet
counts, as well as plasma concentrations of TNF-a,I L -
6, soluble P-selectin, soluble ICAM-1, CD40L and CRP
did not differ (P > 0.05 for all) between diesel exhaust
and filtered air exposures (Table 3).
Discussion
We demonstrate that short-term exposure to diesel
exhaust generated under urban transient engine running
conditions, mimicking a ‘real-world’ urban environment,
impairs vascular vasomotor function and endogenous
fibrinolytic function in human subjects. These vascular
effects are consistent with those reported in studies
employing a similar study protocol, but using an idling
engine. This suggests that different diesel engine run-
ning conditions induce similar adverse vascular
responses.
The ETC urban running condition was selected for
this study as it is based on actual recordings from vehi-
cles, and therefore provides a highly relevant model of
ambient air pollution exposures in urban settings.
Whilst the vascular responses were similar after ETC
urban running conditions and idling, it was found that
the chemical and physical properties differed between
exposure situations. The particles generated under the
transient running setting were slightly larger (according
to the mobility diameter, related to the number concen-
tration) and had a higher elemental carbon to organic
carbon ratio, i.e. more soot and less organics, than those
generated from the idling diesel engine. The PAH pro-
files in the present study were also in good agreement
with previous diesel PAH exhaust studies [26,33].
Furthermore, when comparing the PAH profiles from
the idling and the transient running conditions, they
appeared similar, but with the former having more than
4 times greater concentrations of sum PAHs (ng/m
3)i n
the exposure chamber, mainly related to higher idling
gaseous PAH concentrations. In contrast, PM-associated
PAH concentrations were similar, but differed in profile,
with higher concentrations of phenanthrene, fluor-
anthene and pyrene under transient load and speed con-
ditions (Figure 6). PM-associated PAHs present under
idling conditions were distributed as a higher number of
compounds, including heavier PAH (4-rings) species
(Figure 7). This can be explained by the fact that the
engine’s combustion temperature is at its lowest value
when operating at idling mode. The relatively larger
hydrocarbon emissions at idling reflect unburned fuel
Table 2 Baseline haemodynamic parameters after filtered
air and ETC urban diesel exhaust exposures.
Filtered
air
Diesel
exhaust
Heart rate, bpm 63 ± 1.7 63 ± 2.5
Systolic blood pressure, mmHg 142 ± 3.2 142 ± 2.7
Diastolic blood pressure, mmHg 68 ± 2.9 68 ± 1.8
FBF in infused arm, ml/100 ml tissue/min 3.1 ± 0.3 2.8 ± 0.3
FBF in non-infused arm, ml/100 ml tissue/
min
2.5 ± 0.2 2.9 ± 0.3
Data expressed as mean ± SEM. P > 0.05 for all using paired Student’s t-test
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in the exhaust originates from PAHs originally in the
diesel fuel. It has previously been shown that PAHs in
the diesel fuel represent a significant source for exhaust
PAHs, besides the pyrosynthesis of exhaust PAH [33,34].
The present study demonstrates that inhalation of die-
sel exhaust generated under urban ETC running condi-
tions, causes a reduction in endothelium-dependent and
endothelium-independent vasodilatation, together with
an impairment of t-PA release from the vascular
endothelium. Perturbations of vascular homeostasis are
thought to be important in the triggering of acute myo-
cardial infarction and stroke [8,35]. The vascular assess-
ment in the present study was identical to that used in
previously reported studies employing diesel exhaust
generated under idling conditions [12,13] and was
Figure 4 Forearm blood flow measured six hours after diesel exhaust (solid line) and filtered air (dashed line) exposure during
unilateral intra-brachial infusion of bradykinin (Bk), acetylcholine (Ach), sodium nitroprusside (SNP) and verapamil (Vp) in infused and
non-infused (dotted lines) arms. Effect of exposure compared with using 2-way ANOVA with repeated measures. Data plotted as mean ± SEM.
P-values are given for diesel exhaust exposure vs. air.
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mass concentration of diesel exhaust particles within the
exposure chamber differed slightly between the ETC
and idling exposures (254 versus 330 μg/m
3), as did the
particle properties. Irrespective of a slightly lower PM
mass, difference in particle size and composition, as well
as a lower concentration of PAHs in the present study,
we demonstrated similar adverse vascular responses fol-
lowing exposure to diesel exhaust generated by an
engine under the ETC running conditions compared to
the idling situation.
Interestingly, the present investigation demonstrated
that vasodilatation in response to intra-arterial verapamil
was impaired following diesel exhaust generated under
transient running conditions. This suggests that the vas-
cular smooth muscle also demonstrates a calcium flux-
dependent vasomotor function disturbance, which is not
endothelium-dependent. This has not previously been
shown in studies with idling diesel exhaust that has a
higher content of gaseous (semi volatile) PAH and con-
tains a lower fraction of soot particles than the exhaust
generated under ETC urban conditions. It can thus be
speculated that the higher diesel-related soot content
and its associated (adsorbed) organic material in exhaust
generated under transient running conditions may cause
additional vascular smooth muscle effects, but this issue
will need further investigation.
The oxidative capacity of diesel exhaust particles gen-
erated under idling conditions has previously been con-
firmed by analysis of bronchoalveolar lavage and
bronchial mucosal biopsies sampled from human sub-
jects, as well as in vitro studies [30]. Of note, the oxida-
tive potential of diesel exhaust particles generated in the
present study was less pronounced compared to the
previous idling situation. Whilst certain differences in
particle size, organic carbon/elemental carbon-ratio,
PAH-content and oxidative potential exist between the
two exposure situations, the cardiovascular effects were
generally similar following ETC running conditions
although the verapamil-induced vasodilatation was at
variance to our previous studies. One could speculate
that other exhaust components (particle associated or
gaseous) may be the causal link between the exposure
and the different adverse vascular effects. In this con-
text, Xia et al suggest that organic substances such as
quinones may be important in mediating some of the
cardiovascular effects of diesel exhaust [36]. Quinones
and semi-quinones generated during combustion or cell
metabolism have strong oxidative capacity and may
interact with mitochondria and affect membrane poten-
tial and cell breathing [36,37]. This could be mechanisti-
cally linked to diesel exhaust-induced vascular events, as
well as the increase in ST-segment depression, identified
Figure 5 Net release of t-PA antigen in the infused arm during
unilateral intra-brachial infusion of bradykinin (Bk) after diesel
(solid line) and air (dashed line) exposures. Effect of exposure
compared using 2-way ANOVA with repeated measures. Data
plotted as mean ± SEM.
Table 3 Peripheral blood parameters after filtered air and diesel exhaust exposures.
Before
air exposure
6 hours after
air exposure
Before
diesel exposure
6 hours after
diesel exposure
Leukocytes (× 10
9 cells/L) 5.6 ± 0.3 5.9 ± 0.3 6.0 ± 0.3 5.5 ± 0.2
Neutrophils (× 10
9 cells/L) 2.4 ± 0.2 3.6 ± 0.3 2.6 ± 0.2 3.1 ± 0.2
Platelets (× 10
9 cells/L) 226 ± 8 214 ± 8 229 ± 10 214 ± 8
TNF-a (pg/ml) 0.92 ± 0.21 0.89 ± 0.17 1.03 ± 0.17 0.80 ± 0.17
IL-6 (pg/ml) 0.68 ± 0.22 2.58 ± 0.82 0.60 ± 0.14 2.17 ± 0.76
CRP (mg/l) 1.32 ± 0.52 1.30 ± 0.46 2.03 ± 0.56 1.85 ± 0.56
CD40L (pg/ml) 95.4 ± 9.2 88.8 ± 10.8 98.4 ± 11.1 85.6 ± 11.1
P-Selectin (ng/ml) 52.0 ± 5.7 58.4 ± 7.1 57.4 ± 6.7 54.1 ± 7.4
ICAM-1 (ng/ml) 260.0 ± 13.9 273.1 ± 24.4 267.8 ± 14.2 252.8 ± 17.4
Data expressed as mean ± SEM. P > 0.05 for all using 2-way ANOVA with repeated measures.
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ingly, it is important to further elucidate the role of qui-
nones in mediating the adverse effects of combustion-
related air pollution.
T h e r ew a sad i f f e r e n c ei nN O x concentration and the
ratio NO/NO2 between the present and previous study
employing diesel exhaust exposure at idling. The pub-
lished literature strongly suggests that the vascular
effects present in this and previous experimental expo-
sure studies are due to the presence of combustion-
derived particles in diesel exhaust [8]. It has also been
recently shown that exposure to NO2 does not affect
vascular function [38], which further implies the impor-
tance of a particulate-related source for the vascular
effects following exposure to diesel exhaust. However,
further studies employing particle concentrator technol-
ogies or filtration systems are necessary to clarify the
specific role of the particulate and gaseous components,
other than NOx, in diesel exhaust.
Diesel exhaust induces a complex response in the
human lungs, including oxidative stress, activation of
redox-sensitive transcription factors, inflammatory cell
influx, cell activation and secretion of a range of pro-
inflammatory components [15,17,32,39]. It has been sug-
gested that this pulmonary inflammation would “spill-
over” to the circulation, thereby causing systemic effects.
Systemic inflammation has indeed been implicated as an
important component in atherosclerosis, vasomotor dys-
function and coronary events [30]. However, in the pre-
sent investigation we were unable to demonstrate any
increased systemic inflammation as reflected by CRP,
CD40L, sP-selectin, sICAM-1, IL-6 and TNF-alpha levels
in blood at 6 hours post-exposure. This is in line with
our previous experiences from diesel exhaust exposures
in humans that the presence of major inflammatory
events reflected in the blood is not present during the
early stages after exposure, but in the later stage of 18-24
hours coinciding with the peak inflammatory bronchoal-
veolar response [13,17]. This suggests that the diesel
exhaust-induced vascular responses described here and
in previous diesel exhaust studies using an idling engine
are not related to a systemic inflammatory response.
It has been implied that inhaled diesel exhaust parti-
cles might directly elicit adverse effects outside the
lungs, as inhaled particles are believed to have the
potential to translocate from the alveoli to the vascular
system and subsequently cause effects in the vasculature,
heart and other organs. However, in humans, particle
translocation has not yet been consistently proven
[40-42]. Small numbers of diesel exhaust particles with
their complex highly reactive surfaces, or soluble com-
ponents from these particles, may well reach the circula-
tion, affecting the endothelium in the pulmonary and
peripheral vasculature.
Apart from the running conditions, the exposure pro-
tocol was the same as in previous studies and a similar
particle mass concentration was intended to enable
comparisons. It is recognised that a direct comparison
would benefit from having the different engines and
running modes included within the same study. This
was not possible due to practical issues, and would have
demanded even more extensive resources with dual
engines mounted, as well as multiple exposures and
invasive vascular measurements in the same individuals.
It is concluded that exposure to diesel exhaust gener-
ated during urban transient running conditions, a highly
relevant model of urban air pollution, impairs vasomo-
tor function and endogenous fibrinolysis. These findings
are consistent with previous studies employing an idling
engine and indicate that adverse vascular effects of die-
sel exhaust inhalation occur over different running
Figure 6 Relative distribution (in % of total PAH) for specific
particulate associated PAH compounds for the present ETC
running conditions in comparison with idling conditions used
in previous studies [12,14].
Figure 7 Relative distribution (in % of total PAH) for specific
semi-volatile PAH compounds for the present ETC running
conditions in comparison with idling conditions used in
previous studies [12,14].
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tion and concentrations as well as physicochemical par-
ticle properties. Of note, exposure to diesel exhaust
under urban running conditions was also associated
with a disturbance of calcium channel-dependent vaso-
motor function, not previously demonstrated. This may
suggest that certain cardiovascular endpoints following
exposure to diesel exhaust are related to exhaust proper-
ties in common between the two studied engine running
conditions, whereas the novel calcium flux-related effect
seems to be associated with exhaust properties more
specific for transient load and speed (ETC) conditions,
for example a higher content of diesel soot particles and
their adsorbed organic compounds.
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